PALATIN TECHNOLOGIES, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
PALATIN TECHNOLOGIES, INC. (PTN) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $17.09 thousand as of 2022-06-30, per its 10-K filed 2022-09-22.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2022-09-22
- 2022-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $17.09K.
- 2021-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $235.09K.
- 2020-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount -$168.20K.
- 2020-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.56K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2022-06-30 | $17.09K 10-K · filed 2022-09-22 |
| 2021-06-30 | $235.09K 10-K · filed 2021-09-28 |
| 2020-06-30 | -$168.20K 10-K · filed 2020-09-25 |
| 2020-03-31 | $1.56K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $3.48K 10-Q · filed 2020-02-10 |
| 2019-09-30 | $4.45K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |